Radiation dose associated with local control in advanced anal cancer: Retrospective analysis of 129 patients

Radiotherapy and Oncology

Volumn 87, Issue 3, 2008, Pages 367-375

  Widder, Joachim ^a,b   Kastenberger, Reinhard ^a   Fercher, Elisabeth ^a   Schmid, Rainer ^a   Langendijk, Johannes A ^b   Dobrowsky, Werner ^c   Pötter, Richard ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c Northern Centre for Cancer Treatment   (United Kingdom)

Author keywords

Anal cancer or carcinoma; Chemoradiation; Dose response; Radiotherapy

Indexed keywords

FLUOROURACIL; MITOMYCIN C;

ADULT; AGED; ANUS CANCER; ARTICLE; BRACHYTHERAPY; CANCER CONTROL; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COLOSTOMY; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HEART FAILURE; HUMAN; INCONTINENCE; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; RADIATION DOSE; RETROSPECTIVE STUDY; RISK FACTOR; ULCER;

ADULT; AGED; AGED, 80 AND OVER; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY DOSAGE; SURVIVAL RATE;

EID: 46549088358     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.05.001     Document Type: Article

References (43)

1. UKCCCR Anal Cancer Trial Working Party. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research. Lancet 1996;348:1049-54.
2. Bartelink H., Roelofsen F., Eschwege F., et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European organization for research and treatment of cancer radiotherapy and gastrointestinal cooperative groups. J Clin Oncol 15 (1997) 2040-2049
3. Nigro N.D., Vaitkevicius V.K., and Considine Jr. B. Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 17 (1974) 354-356
4. Flam M., John M., Pajak T.F., et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol 14 (1996) 2527-2539
5. Ajani J.A., Winter K.A., Gunderson L.L., et al. Intergroup RTOG 98-11: a phase III randomized study of 5-fluorouracil (5-FU), mitomycin, and radiotherapy versus 5-fluorouracil, cisplatin and radiotherapy in carcinoma of the anal canal. J Clin Oncol 24 (2006) 4009
6. Eschwege F., Lasser P., Chavy A., et al. Squamous cell carcinoma of the anal canal: treatment by external beam irradiation. Radiother Oncol 3 (1985) 145-150
7. Papillon J., Montbarbon J.F., Gerard J.P., Chassard J.L., and Ardiet J.M. Interstitial curietherapy in the conservative treatment of anal and rectal cancers. Int J Radiat Oncol Biol Phys 17 (1989) 1161-1169
8. Goldman S., Glimelius B., Glas U., Lundell G., Påhlman L., and Ståhle E. Management of anal epidermoid carcinoma - an evaluation of treatment results in two population-based series. Int J Colorectal Dis 4 (1989) 234-243
9. Newman G., Calverley D.C., Acker B.D., Manji M., Hay J., and Flores A.D. The management of carcinoma of the anal canal by external beam radiotherapy, experience in Vancouver 1971-1988. Radiother Oncol 25 (1992) 196-202
10. Gerard J.P., Mauro F., Thomas L., et al. Treatment of squamous cell anal canal carcinoma with pulsed dose rate brachytherapy. Feasibility study of a French cooperative group. Radiother Oncol 51 (1999) 129-131
11. Kapp K.S., Geyer E., Gebhart F.H., et al. Experience with split-course external beam irradiation +/- chemotherapy and integrated Ir-192 high-dose-rate brachytherapy in the treatment of primary carcinomas of the anal canal. Int J Radiat Oncol Biol Phys 49 (2001) 997-1005
12. Mitchell S.E., Mendenhall W.M., Zlotecki R.A., and Carroll R.R. Squamous cell carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 49 (2001) 1007-1013
13. Bruna A., Gastelblum P., Thomas L., et al. Treatment of squamous cell anal canal carcinoma (SCACC) with pulsed dose rate brachytherapy: a retrospective study. Radiother Oncol 79 (2006) 75-79
14. Das P., Bhatia S., Eng C., et al. Predictors and patterns of recurrence after definitive chemoradiation for anal cancer. Int J Radiat Oncol Biol Phys 68 (2007) 794-800
15. Chen Y.J., Liu A., Tsai P.T., et al. Organ sparing by conformal avoidance intensity-modulated radiation therapy for anal cancer: dosimetric evaluation of coverage of pelvis and inguinal/femoral nodes. Int J Radiat Oncol Biol Phys 63 (2005) 274-281
16. Milano M.T., Jani A.B., Farrey K.J., Rash C., Heimann R., and Chmura S.J. Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome. Int J Radiat Oncol Biol Phys 63 (2005) 354-361
17. Ferrigno R., Nakamura R.A., Dos Santos Novaes P.E., et al. Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness. Int J Radiat Oncol Biol Phys 61 (2005) 1136-1142
18. Lang S., Kirisits C., Dimopoulos J., Georg D., and Pötter R. Treatment planning for MRI assisted brachytherapy of gynecologic malignancies based on total dose constraints. Int J Radiat Oncol Biol Phys 69 (2007) 619-627
19. Dobrowsky W. Radiotherapy of epidermoid anal canal cancer. Br J Radiol 62 (1989) 53-58
20. Whiteford M.H., Stevens Jr. K.R., Oh S., and Deveney K.E. The evolving treatment of anal cancer: How are we doing?. Arch Surg 136 (2001) 886-891
21. Gerard J.P., Ayzac L., Hun D., et al. Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil-cisplatinum. Long-term results in 95 patients. Radiother Oncol 46 (1998) 249-256
22. Peiffert D., Giovannini M., Ducreux M., et al. High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: final results of a phase II study. Ann Oncol 12 (2001) 397-404
23. Nilsson P.J., Svensson C., Goldman S., Ljungqvist O., and Glimelius B. Epidermoid anal cancer: a review of a population-based series of 308 consecutive patients treated according to prospective protocols. Int J Radiat Oncol Biol Phys 61 (2005) 92-102
24. Papillon J., and Montbarbon J.F. Epidermoid carcinoma of the anal canal. A series of 276 cases. Dis Colon Rectum 30 (1987) 324-333
25. Deniaud-Alexandre E., Touboul E., Tiret E., et al. Results of definitive irradiation in a series of 305 epidermoid carcinomas of the anal canal. Int J Radiat Oncol Biol Phys 56 (2003) 1259-1273
26. Tournier-Rangeard L., Peiffert D., Lafond C., et al. Long-term results and prognostic factors of squamous cell carcinoma of the anal canal treated by irradiation. Cancer Radiother 11 (2007) 169-177
27. Chapet O., Gerard J.P., Riche B., Alessio A., Mornex F., and Romestaing P. Prognostic value of tumor regression evaluated after first course of radiotherapy for anal canal cancer. Int J Radiat Oncol Biol Phys 63 (2005) 1316-1324
28. Peiffert D., Bey P., Pernot M., et al. Conservative treatment by irradiation of epidermoid cancers of the anal canal: prognostic factors of tumoral control and complications. Int J Radiat Oncol Biol Phys 37 (1997) 313-324
29. de Bree E., van Ruth S., Dewit L.G., and Zoetmulder F.A. High risk of colostomy with primary radiotherapy for anal cancer. Ann Surg Oncol 14 (2007) 100-108
30. Hughes L.L., Rich T.A., Delclos L., Ajani J.A., and Martin R.G. Radiotherapy for anal cancer: experience from 1979-1987. Int J Radiat Oncol Biol Phys 17 (1989) 1153-1160
31. Constantinou E.C., Daly W., Fung C.Y., Willett C.G., Kaufman D.S., and DeLaney T.F. Time-dose considerations in the treatment of anal cancer. Int J Radiat Oncol Biol Phys 39 (1997) 651-657
32. Vuong T., Kopek N., Ducruet T., et al. Conformal therapy improves the therapeutic index of patients with anal canal cancer treated with combined chemotherapy and external beam radiotherapy. Int J Radiat Oncol Biol Phys 67 (2007) 1394-1400
33. Das P., Crane C.H., and Ajani J.A. Current treatment for localized anal carcinoma. Curr Opin Oncol 19 (2007) 396-400
34. Huang K., Haas-Kogan D., Weinberg V., and Krieg R. Higher radiation dose with a shorter treatment duration improves outcome for locally advanced carcinoma of anal canal. World J Gastroenterol 13 (2007) 895-900
35. Vordermark D., Sailer M., Flentje M., Thiede A., and Kölbl O. Curative-intent radiation therapy in anal carcinoma: quality of life and sphincter function. Radiother Oncol 52 (1999) 239-243
36. Allal A.S., Sprangers M.A., Laurencet F., Reymond M.A., and Kurtz J.M. Assessment of long-term quality of life in patients with anal carcinomas treated by radiotherapy with or without chemotherapy. Br J Cancer 80 (1999) 1588-1594
37. Salama J.K., Mell L.K., Schomas D.A., et al. Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience. J Clin Oncol 25 (2007) 4581-4586
38. Poggi M.M., Suh W.W., Saltz L., et al. ACR appropriateness criteria on treatment of anal cancer. J Am Coll Radiol 4 (2007) 448-456
39. Meyer J., Czito B., Yin F.F., and Willett C. Advanced radiation therapy technologies in the treatment of rectal and anal cancer: intensity-modulated photon therapy and proton therapy. Clin Colorectal Cancer 6 (2007) 348-356
40. Myerson R.J., Kong F., Birnbaum E.H., et al. Radiation therapy for epidermoid carcinoma of the anal canal, clinical and treatment factors associated with outcome. Radiother Oncol 61 (2001) 15-22
41. Gerard J.P., Chapet O., Samiei F., et al. Management of inguinal lymph node metastases in patients with carcinoma of the anal canal: experience in a series of 270 patients treated in Lyon and review of the literature. Cancer 92 (2001) 77-84
42. Weber D.C., Kurtz J.M., and Allal A.S. The impact of gap duration on local control in anal canal carcinoma treated by split-course radiotherapy and concomitant chemotherapy. Int J Radiat Oncol Biol Phys 50 (2001) 675-680
43. Hatfield P., Cooper R., and Sebag-Montefiore D. Involved-field, low-dose chemoradiotherapy for early-stage anal carcinoma. Int J Radiat Oncol Biol Phys 70 (2008) 419-424